CytoDyn’s Phase 2 Study of Leronlimab for Mild-to-Moderate COVID-19 Selected for Oral Presentation at the Special isirv-AVG Virtual Conference on ‘Therapeutics for COVID-19’

VANCOUVER, Washington, Sept. 22, 2020 (GLOBE NEWSWIRE) — CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company”), a late-stage biotechnology company developing

Read more

Applied Biosciences Hires Former Pfizer Business Unit Chief Medical Officer as Chief Executive Officer

LOS ANGELES, May 07, 2019 (GLOBE NEWSWIRE) — Applied BioSciences Corp. (OTCQB: APPB), a diversified cannabinoid-based therapeutics company focused on

Read more

Applied BioSciences Retains the Emmes Group to Partner on Therapeutic Development Initiatives

LOS ANGELES, CA / ACCESSWIRE / April 8, 2019 / Applied Biosciences Corp. (OTCQB: APPB), a diversified cannabinoid therapeutics company focused

Read more

Applied BioSciences Announces Partnership with Boxing Heavyweight Champion Shannon Briggs

LOS ANGELES, March 20, 2019 (GLOBE NEWSWIRE) — Applied Biosciences Corp. (OTCQB: APPB), a diversified cannabinoid therapeutics company focused on

Read more